Nagoya, Japan

Kougaku Isogawa

This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kougaku Isogawa. Retrieved from https://idiyas.com/inventor/kougaku-isogawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kougaku Isogawa: Innovator in Glycyrrhetinic Acid Derivatives

Introduction

Kougaku Isogawa is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on glycyrrhetinic acid derivatives. His research focuses on developing novel compounds that can be utilized in the treatment of viral infections.

Latest Patents

Kougaku Isogawa holds a patent for glycyrrhetinic acid derivatives. This invention provides a novel glycoside that contains as the aglycon a 4-(substituted phenyl)piperazine-1-yl derivative of glycyrrhetinic acid and 11-deoxo-glycyrrhetinic acid or their derivatives. The composition is designed for the treatment of virus infections, with these compounds serving as the main active components. He has 1 patent to his name.

Career Highlights

Isogawa is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community for its potential applications in medicine.

Collaborations

Throughout his career, Kougaku Isogawa has collaborated with esteemed colleagues, including Masayasu Kurono and Yoshiro Ishiwata. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field.

Conclusion

Kougaku Isogawa is a prominent figure in the realm of medicinal chemistry, with a focus on glycyrrhetinic acid derivatives. His contributions have the potential to impact the treatment of viral infections significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…